ArticleLeukemia & lymphoma2009

Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.

Xavier Poiré et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.